IL106743A - Tablets with enhanced bioavailability of claudonic acid - Google Patents

Tablets with enhanced bioavailability of claudonic acid

Info

Publication number
IL106743A
IL106743A IL10674393A IL10674393A IL106743A IL 106743 A IL106743 A IL 106743A IL 10674393 A IL10674393 A IL 10674393A IL 10674393 A IL10674393 A IL 10674393A IL 106743 A IL106743 A IL 106743A
Authority
IL
Israel
Prior art keywords
tablet
tablets
weight
content
active material
Prior art date
Application number
IL10674393A
Other languages
English (en)
Hebrew (he)
Other versions
IL106743A0 (en
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25927331&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL106743(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE9307393U external-priority patent/DE9307393U1/de
Priority claimed from DE19934322057 external-priority patent/DE4322057A1/de
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of IL106743A0 publication Critical patent/IL106743A0/xx
Publication of IL106743A publication Critical patent/IL106743A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL10674393A 1993-05-15 1993-08-19 Tablets with enhanced bioavailability of claudonic acid IL106743A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE9307393U DE9307393U1 (de) 1993-05-15 1993-05-15 Tablette mit verbesserter Bioverfügbarkeit, enthaltend Dichlormethylendiphosphonsäure als Wirkstoff
DE19934322057 DE4322057A1 (de) 1993-07-02 1993-07-02 Tablette mit verbesserter Bioverfügbarkeit enthaltend Dichlormethylendiphosphonsäure als Wirkstoff

Publications (2)

Publication Number Publication Date
IL106743A0 IL106743A0 (en) 1993-12-08
IL106743A true IL106743A (en) 1999-11-30

Family

ID=25927331

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10674393A IL106743A (en) 1993-05-15 1993-08-19 Tablets with enhanced bioavailability of claudonic acid

Country Status (25)

Country Link
US (1) US5650168A (ko)
EP (2) EP0697890A1 (ko)
JP (1) JP3699110B2 (ko)
KR (1) KR100263284B1 (ko)
CN (1) CN1041797C (ko)
AT (2) ATE128363T1 (ko)
AU (1) AU687744B2 (ko)
BR (1) BR9307859A (ko)
CA (1) CA2162470C (ko)
CZ (1) CZ287984B6 (ko)
DE (1) DE59300688D1 (ko)
DK (1) DK0625355T5 (ko)
ES (1) ES2065313T5 (ko)
FI (1) FI111519B (ko)
GR (2) GR940300095T1 (ko)
HU (1) HU220872B1 (ko)
IL (1) IL106743A (ko)
NO (1) NO307548B1 (ko)
NZ (1) NZ254765A (ko)
PL (1) PL173026B1 (ko)
RU (1) RU2134103C1 (ko)
SK (1) SK281193B6 (ko)
TW (1) TW350772B (ko)
UA (1) UA39884C2 (ko)
WO (1) WO1994026310A1 (ko)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI94926C (fi) * 1993-11-12 1995-11-27 Leiras Oy Menetelmä klodronaattivalmisteen valmistamiseksi
DE19615812A1 (de) * 1996-04-20 1997-10-23 Boehringer Mannheim Gmbh Pharmazeutische Zubereitung enthaltend Diphosphonsäuren zur oralen Applikation
DE19719680A1 (de) 1997-05-09 1998-11-19 Boehringer Mannheim Gmbh Verwendung von Diphosphonsäuren zur präventiven Behandlung von Spätfolgen bei Harnblasenerweiterung oder Harnblasenersatz
FI109088B (fi) * 1997-09-19 2002-05-31 Leiras Oy Tabletti ja menetelmä sen valmistamiseksi
EP0998932A1 (de) 1998-10-09 2000-05-10 Boehringer Mannheim Gmbh Feste pharmazeutische Darreichungsform enthaltend Diphosphonsäure oder deren Salze und Verfahren zu ihrer Herstellung
SE9901272D0 (sv) * 1999-04-09 1999-04-09 Astra Ab New improved formulation
CZ20002567A3 (cs) * 2000-07-11 2001-12-12 Léčiva, A.S. Tableta vyrobitelná přímým tabletováním, obsahující aktivní látku kyselinu 4-amino-1-hydroxybutyliden-1,1-bisfosfonovou, a způsob její výroby
US10213387B2 (en) 2003-09-19 2019-02-26 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
US10226428B2 (en) 2003-09-19 2019-03-12 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
US8163306B2 (en) * 2003-09-19 2012-04-24 Sun Pharma Advanced Research Company Oral drug delivery system
US7151400B2 (en) * 2004-07-13 2006-12-19 Taiwan Semiconductor Manufacturing Company, Ltd. Boost-biased level shifter
CN100370972C (zh) * 2006-01-10 2008-02-27 北京申科联华科技有限公司 一种具有益气养阴、活血复脉功效的片剂及制备方法
EP2177219A4 (en) * 2007-08-02 2010-09-29 Teijin Pharma Ltd PROPHYLACTIC OR THERAPEUTIC FOR DISEASES AS A RESULT OF ABNORMAL BONE MATERIAL CHANGE
WO2009122431A2 (en) * 2008-02-15 2009-10-08 Sun Pharma Advanced Research Company Ltd., Oral controlled release tablet
CN118370733B (zh) * 2024-06-21 2024-10-01 山东新时代药业有限公司 一种钙代谢调节药物氯膦酸二钠片及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2813121A1 (de) * 1977-03-29 1978-10-12 Procter & Gamble Verwendung von dichlormethan-diphosphonatverbindungen bei der bekaempfung von collagen-erkrankungen und zur wundheilung
US4634691A (en) * 1980-10-07 1987-01-06 The Procter & Gamble Company Method for inhibiting tumor metastasis
US4517179A (en) * 1983-04-29 1985-05-14 Pennwalt Corporation Rapid dissolving, uniform drug compositions and their preparation
SE457326B (sv) * 1986-02-14 1988-12-19 Lejus Medical Ab Foerfarande foer framstaellning av en snabbt soenderfallande kaerna innehaallande bl a mikrokristallin cellulosa
DE3767998D1 (de) * 1986-12-20 1991-03-14 Boehringer Mannheim Gmbh Clodronat-haltige arzneimittel und verfahren zur herstellung derselben.
DE3804686A1 (de) * 1988-02-15 1989-08-24 Henkel Kgaa Arzneimittel mit einer kombination von cytostatika bzw. hormontherapeutika und phosphonoderivaten
FR2629716B1 (fr) * 1988-04-07 1991-07-19 Sanofi Sa Composition pharmaceutique pour administration orale a base d'un derive d'acide diphosphonique
FI83421C (fi) † 1989-06-21 1991-07-10 Huhtamaeki Oy Foerfarande foer framstaellning av farmakologiskt anvaendbara metylenbisfosfonsyraderivat.
ATE119777T1 (de) * 1991-02-26 1995-04-15 Procter & Gamble Pharma Behandlungsmethoden für osteoporose.
SE501389C2 (sv) * 1992-04-24 1995-01-30 Leiras Oy Farmaceutiskt preparat och förfarande för dess framställning
AU5953894A (en) * 1992-12-23 1994-07-19 Merck & Co., Inc. Bisphosphonate/estrogen therapy for treating and preventing bone loss

Also Published As

Publication number Publication date
HU9403160D0 (en) 1995-02-28
WO1994026310A1 (de) 1994-11-24
CA2162470A1 (en) 1994-11-24
KR100263284B1 (ko) 2000-08-01
KR960702322A (ko) 1996-04-27
AU687744B2 (en) 1998-03-05
FI945313A (fi) 1994-12-13
NZ254765A (en) 1997-02-24
PL173026B1 (pl) 1998-01-30
DK0625355T5 (da) 2003-12-01
EP0625355B1 (de) 1995-09-27
CZ10095A3 (en) 1995-10-18
CN1095267A (zh) 1994-11-23
EP0625355B2 (de) 2003-06-25
PL307133A1 (en) 1995-05-02
DK0625355T4 (da) 2003-10-06
NO307548B1 (no) 2000-04-25
ATE128363T1 (de) 1995-10-15
BR9307859A (pt) 1996-01-09
TW350772B (en) 1999-01-21
JP3699110B2 (ja) 2005-09-28
AU4702093A (en) 1994-12-12
HU220872B1 (en) 2002-06-29
SK4895A3 (en) 1997-01-08
DE59300688D1 (de) 1995-11-02
HUT70214A (en) 1995-09-28
CA2162470C (en) 1998-06-16
CN1041797C (zh) 1999-01-27
DK0625355T3 (da) 1995-12-27
AT128U1 (de) 1995-03-27
GR940300095T1 (en) 1995-01-31
ES2065313T1 (es) 1995-02-16
IL106743A0 (en) 1993-12-08
JPH08509697A (ja) 1996-10-15
NO944405D0 (no) 1994-11-17
RU2134103C1 (ru) 1999-08-10
FI945313A0 (fi) 1994-11-11
CZ287984B6 (cs) 2001-03-14
US5650168A (en) 1997-07-22
GR3017547T3 (en) 1995-12-31
SK281193B6 (sk) 2001-01-18
ES2065313T5 (es) 2004-01-01
FI111519B (fi) 2003-08-15
UA39884C2 (uk) 2001-07-16
NO944405L (no) 1994-11-24
ES2065313T3 (es) 1995-12-01
EP0625355A1 (de) 1994-11-23
EP0697890A1 (de) 1996-02-28

Similar Documents

Publication Publication Date Title
US20110177168A1 (en) Composition
US9827197B2 (en) Diclofenac formulations and methods of use
FI101040B (fi) Menetelmä sentraalisten dopamiininpuutostilojen hoitoon tarkoitetun, p eroraalisesti annettavan lääkemuodon valmistamiseksi
IL106743A (en) Tablets with enhanced bioavailability of claudonic acid
HU227759B1 (en) Improved pharmaceutical formulations containing ibuprofen and codeine
JP2893307B2 (ja) ニコランジルの製薬的に安定な製剤
UA52682C2 (uk) Таблетка малеату тримебутину в оболонці
WO2002058666A2 (en) Process for preparing non-hygroscopic sodium valproate composition
JPS6036424A (ja) 液体潤滑剤を含有する医薬組成物
IL139407A (en) Oral preparations containing -8 chloro-6, 11 - dihydro-11 - (-4-piperidaldehyde) - H5-benzo [5, 6] cyclohepta [1, -2 [b-pyridine
AU756338B2 (en) Stabile compositions comprising levosimendan and alginic acid
WO2019014201A1 (en) MOLINDONE COMPOSITIONS WITH EXTENDED RELEASE
GB2336999A (en) High-dosage triclosan compositions
US3842169A (en) Composition and method for treatment of pathological calcification in animals
RU2106141C1 (ru) Способ получения лекарственной формы ненаркотического анальгетика
AU2002241960A1 (en) Process for preparing non-hygroscopic sodium valproate composition

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired